Smoking, Platelet Reactivity and Fibrinogen

  • Jack Kutti
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 273)


It is universally accepted that smoking constitutes a major independent risk factor for the development of atherosclerosis as well as arterial thrombosis formation and its most serious consequences, i.e., coronary artery disease/acute myocardial infarction and stroke (A Report of the Surgeon General, 1983). Likewise, it is well recognized that platelets play an important role in the development of occlusive arterial disease (Schafer and Handin, 1979); there is indeed substantial evidence to suggest that abnormal platelet/vessel wall interaction is involved in the pathogenesis of the atherosclerotic lesion itself (Weksler and Nachman, 1981; Hoak, 1988). Also, a strong association between plasma fibrinogen concentration and platelet aggregability was reported by Meade et al. (1985). In atherosclerosis, lipids and fibrinogen accumulate in the subintimal layers of the arterial wall. Fibrinogen is an acute phase protein and plasma concentrations rise as a result of a wide range of stimuli many of which are of a non-specific nature, e.g., chronic inflammatory disorders, after surgery, in malignant disease and during pregnancy. Indeed, atheroma displays some of the characteristics of an inflammatory response. The present article attempts to review some of the concepts as to how smoking relates to platelet reactivity and plasma fibrinogen concentration, and thereby to arterial vascular disease.


Platelet Aggregation Bleeding Time Platelet Reactivity Plasma Fibrinogen Habitual Smoker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. A Report of the Surgeon General. The health consequences of smoking: cardiovascular disease. US Department of Health and Human Services, Rockville, MD. (1983).Google Scholar
  2. Ahlsten, G., Ewald, U., and Tuvemo, T. Arachidonic-acid-induced platelet aggregation is increased in male but not in female smokers, Prostaglandins Leukotrienes Med, 21:149 (1986).CrossRefGoogle Scholar
  3. Belch, J. J. F., McArdle, B. M., Burns, P., Lowe, G. D. O., and Forbes, C. D. The effects of acute smoking on platelet behaviour, fibrinolysis and haemorheology in habitual smokers, Thromb Haemost, 51:6. (1984).PubMedGoogle Scholar
  4. Berglund, U., Wallentin, L., and von Schenck, H. Platelet function and plasma fibrinogen and their relations to gender, smoking habits, obesity and beta-blocker treatment in young survivors of myocardial infarction, Thromb Haemost, 60:21 (1988).PubMedGoogle Scholar
  5. Carlsson, I., and Wennmalm, Å. Platelet aggregability in smoking and non-smoking subjects, Clin Physiol, 3:565 (1983).PubMedCrossRefGoogle Scholar
  6. Chao, F. C, Tullis, J. L., Alper, C. A., Glynn, R. J., and Sibert, J. E. Alterations in plasma proteins and platelet functions with aging and cigarette smoking in healthy men, Thromb Haemost, 47:259 (1982).PubMedGoogle Scholar
  7. Davis, R. F. and Davis, J. W. The effect of smoking on the stressed template bleeding time, Ann Clin Res, 15:131 (1983).PubMedGoogle Scholar
  8. Dotevall, A., Kutti, J., Teger-Nilsson, A. C, Wadenvik, H., and Wilhelmsen L. Platelet reactivity, fibrinogen and smoking, Eur J Haematol, 38:55 (1987).PubMedCrossRefGoogle Scholar
  9. Fuster, V., Chesebro, J. H., Frye, R. L., and Elveback, L. R. Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy, Circulation, 63:546 (1981).PubMedCrossRefGoogle Scholar
  10. Harker, L. A., and Slichter, S. J. The bleeding time as a screening test for evaluation of platelet function, N Engl J Med, 187:155 (1972).CrossRefGoogle Scholar
  11. Hoak, J. C. Platelets and atherosclerosis, Semin Thromb Hemost, 14:202 (1988).PubMedCrossRefGoogle Scholar
  12. Kampman, M. T., and Hornstra, G. No acute effect of cigarette smoking, and risk of cardiovascular disease: insights from the Framingham study, Am Heart J, 113:1006 (1987).CrossRefGoogle Scholar
  13. Lassila, R., and Laustiola, K. E. Physical exercise provokes platelet desensitization in men who smoke cigarettes — involvement of sympathoadrenergic mechanisms — a study of monozygotic twin pairs discordant for smoking, Thromb Res, 51:145 (1988).PubMedCrossRefGoogle Scholar
  14. Lassila, R. The platelet α2-adrenoceptor and prostacyclin sensitivity are not altered by cigarette smoking — a study of monozygotic twin pairs discordant for smoking, Thromb Res, 54:339 (1989).PubMedCrossRefGoogle Scholar
  15. László, E., Káldi, N., and Kovács, L. Alterations in plasma proteins and platelet functions with aging and cigarette smoking in healthy men, Thromb Haemost, 49:150 (1983).PubMedGoogle Scholar
  16. Levine, P. H. An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis, Circulation, 48:619 (1973).PubMedGoogle Scholar
  17. Madsen, H., and Dyerberg, J. Cigarette smoking and its effect on platelet-vessel wall interaction, Scand J Clin Lab Invest, 44:203 (1984).PubMedCrossRefGoogle Scholar
  18. Mansouri, A., and Perry, C. A. Alteration of platelet aggregation by cigarette smoke and carbon monoxide, Thromb Haemost, 48:286 (1982).PubMedGoogle Scholar
  19. Meade, T. W., Chakrabarti, R., Haines, A. P., North, W. R. S., Stirling, Y., Thompson, S. G., and Brozovic, M. Haemostatic function and cardiovascular death: early results of a prospective study, Lancet, 1:1050 (1980).PubMedCrossRefGoogle Scholar
  20. Meade, T. W., Vickers, M. V., Thompson, S. G., Stirling, Y., Haines, A. P., and Miller, G. J. Epidemiological characteristics of platelet aggregability, Br Med J, 290:428 (1985).CrossRefGoogle Scholar
  21. Mielke, C. H. Aspirin prolongation of the template bleeding time: influence of venostasis and direction of incision, Blood, 60:1139 (1982).PubMedGoogle Scholar
  22. Modesti, P. A. Abbate, R., Gensini, G. F., Colella, A., and Neri Serneri, G. G. Platelet thromboxane A2 receptors in habitual smokers. Thromb Res, 55:195 (1989). Peerschke, E. I. B. The platelet fibrinogen receptor, Semin Hematol, 22:241 (1985).PubMedCrossRefGoogle Scholar
  23. Peerschke, E. I. B. The platelet fibrinogen receptor, Semin Hematol, 22:241 (1985)PubMedGoogle Scholar
  24. Pittilo, R. M., Clarke, J. M. F., Harris, D., Mackie, I. J., Rowles, P. M., Machin, S. J., and Woolf, N. Cigarette smoking and platelet adhesion, Br J Haematol, 58:627 (1984).PubMedCrossRefGoogle Scholar
  25. Ring, T., Kristensen, S. D., Jensen, P. N., Mourits-Andersen, T., Madsen, H., and Dyerberg, J. Cigarette smoking shortens the bleeding time, Thromb Res, 32:531 (1983).PubMedCrossRefGoogle Scholar
  26. Rival, J., Riddle, J. M., and Stein, P. D. Effects of chronic smoking on platelet function, Thromb Res, 45:75 (1987).PubMedCrossRefGoogle Scholar
  27. Rosengren, A., Wilhelmsen, L., Welin, L., Teger-Nilsson, A. C, and Tsipogianni, A. Social influences and cardiovascular risk factors as determinants of plasma fibrinogen in a general population sample of middle-aged men (submitted for publication) (1989)Google Scholar
  28. Schafer, A. I., and Handin, R. I. The role of platelets in thrombotic and vascular disease, Prog Cardiovasc Dis, 22:31 (1979).PubMedCrossRefGoogle Scholar
  29. Schmidt, K. G., and Rasmussen, J. W. Acute platelet activation induced by smoking. In vivo and ex vivo studies in humans, Thromb Haemost, 51:279 (1984).PubMedGoogle Scholar
  30. Siess, W., Lorenz, R., Roth, P., and Weber, P. C. Plasma catecholamines platelet aggregation and associated thromboxane formation after physical exercise, smoking or norepinephrine infusion, Circulation, 66:44 (1982).PubMedCrossRefGoogle Scholar
  31. Steen, V. M., and Holmsen, H. Current aspects on human platelet activation, Eur J Haematol, 38:383 (1987).PubMedCrossRefGoogle Scholar
  32. Vicari, A. M., Margonato, A., Macagni, A., Luoni, R., Seveso, M. P., Vicedomini, G., and Pozza, G. Effects of acute smoking on the hemostatic system in humans, Clin Cardiol, 11:538 (1988).PubMedCrossRefGoogle Scholar
  33. Vilen, L., Jacobsson, S., Wadenvik, H., and Kutti, J. ADP-induced platelet aggregation as a function of age in healthy humans, Thromb Haemost, 61:490 (1989).PubMedGoogle Scholar
  34. Weksler, B. B., and Nachman, R. L. Platelets and atherosclerosis, Am J Med, 71:331 (1981).PubMedCrossRefGoogle Scholar
  35. Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., and Tibblin, G. Fibrinogen as a risk factor for stroke and myocardial infarction, N Engl J Med, 311:501 (1984).PubMedCrossRefGoogle Scholar
  36. Wiseman, S., Kenchington, G., Dain, R., Marshall, C. E., McCollum, C. N., Greenhalgh, R. M., and Powell, J. T. Influence of smoking and plasma factors on patency of femoropopliteal vein grafts, Br Med J, 299:643 (1989).CrossRefGoogle Scholar
  37. Wu, K. K., and Hoak, J. C. A new method for the quantitative detection of platelet aggregation in patients with arterial insufficiency, Lancet, 2:924 (1974).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Jack Kutti
    • 1
  1. 1.Department of Medicine, Östra HospitalUniversity of GöteborgGöteborgSweden

Personalised recommendations